Involvement of the DNA mismatch repair system in antineoplastic drug resistance

Journal of Cancer Research and Clinical Oncology

Volumn 125, Issue 3-4, 1999, Pages 156-165

  Lage, Hermann ^a   Dietel, Manfred ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

DNA mismatch repair; Drug resistance; MLH1; MSH2; MSH3; MSH6; MutL; MutS; PMS2

Indexed keywords

BUSULFAN; CISPLATIN; DOXORUBICIN; ETOPOSIDE; MERCAPTOPURINE; METHYLNITRONITROSOGUANIDINE; METHYLNITROSOUREA; PROCARBAZINE; TEMOZOLOMIDE; TIOGUANINE;

BASE MISPAIRING; CANCER CHEMOTHERAPY; DNA REPAIR; DRUG EFFICACY; GENE MUTATION; GENETIC VARIABILITY; HUMAN; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL; REVIEW;

EID: 0032907596     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004320050258     Document Type: Review

References (85)

1. Acharya S, Wilson T, Gradia S, Kane MF, Guerrette S, Mrasischky GT, Kolodner R, Fishel R (1996) hMSH2 forms specific mispair-binding complexes with hMSH3 and hMSH6. Proc Natl Acad Sci USA 93:13 629-13 634
2. Aebi S, Kurdi-Haidar B, Gordon R, Cenni B, Zheng H, Fink D, Christen RD, Boland CR, Koi M, Fishel R, Howell SB (1996) Loss of DNA mismatch repair in acquired resistance to cisplatin. Cancer Res 56:3087-3090
3. Aebi S, Fink D, Gordon R, Kim HK, Zheng H, Fink JL, Howell SB (1997) Resistance to cytotoxic drugs in DNA mismatch repair-deficient cells. Clin Cancer Res 3:1763-1767
4. Alas MM de las, Aebi S, Fink D, Howell SB, Los G (1997) Loss of DNA mismatch repair: effects on the rate of mutation to drug resistance. J Natl Cancer Inst 89:1537-1541
5. Baker SM, Annemieke WP, Prolla TA, Bronner CE, Harris AC, Yao X, Christie D, Monell C, Arnheim N, Bradley A, Ashley T, Liskay RM (1996) Involvement of mouse MLH1 in DNA mismatch repair and meiotic crossing over. Nat Genet 13:336-342
6. Baskaran R, Chiang GG, Wang JYJ (1996) Identification of a binding site in c-Abl tyrosine kinase for the C-terminal repeated domain of RNA polymerase II. Mol Cell Biol 16:3361-3369
7. Ben-Yehuda D, Krichevsky S, Caspi O, Rund D, Polliack A, Abeliovich D, Zelig O, Yahalom V, Paltiel O, Or R, Peretz T, Ben-Neriah S, Yehuda O, Rachmilewitz EA (1996) Microsatellite instability and p53 mutations in therapy-related leukemia suggest mutator phenotype. Blood 88:4296-4303
8. Boyer JC, Umar A, Risinger JI, Lipford JR, Kane M, Yin S, Barrett JC, Kolodner RD, Kunkel TA (1995) Microsatellite instability, mismatch repair deficiency, and genetic defects in human cancer cell lines. Cancer Res 55:6063-6070
9. Brentnall TA, Chen R, Lee JG, Kimmey MB, Bronner MP, Haggit RC, Kowdley KV, Hecker LM, Byrd DR (1995) Microsatellite instability and K-ras mutations associated with pancreatic adenocarcinoma and pancreatitis. Cancer Res 55:4264-4267
10. Brimmell M, Mendiola R, Mangion J, Packham G (1998) BAX frameshift mutations in cell lines derived from human haemopoietic malignancies are associated with resistance to apoptosis and microsatellite instability. Oncogene 16:1803-1812
11. Bronner CE, Baker SM, Morrison PT, Warren G, Smith LG, Lescoe MK, Kane M, Earabino C, Lipford J, Lindblom A, Tannergard P, Bollag RJ, Godwin AR, Ward DC, Nordenskjold M, Fishel R, Kolodner R, Liskay RM (1994) Mutation in the DNA mismatch repair gene homologue hMLH1 is associated with hereditary non-polyposis colon cancer. Nature 368:258-261
12. Brown R, Hirst GL, Gallagher WM, Mcllwrath AJ, Margison GP, van der Zee AGJ, Anthoney DA (1997) hMLH1 expression and cellular responses of ovarian tumour cells to treatment with cytotoxic: anticancer agents. Oncogene 15:45-52
13. Calsou P, Salles B (1993) Role of DNA repair in the mechanisms of cell resistance to alkylating agents and cisplatin. Cancer Chemother Pharmacol 32:85-89
14. Carethers JM, Hawn MT, Chauhan DP, Luce MC, Marra G, Koi M, Boland CR (1998) Competency in mismatch repair prohibits clonal expansion of cancer cells treated with N-methyl-N′-nitro-N-nitrosoguanidine. J Clin Invest 98:199-206
15. Chen AY, Liu LF (1994) DNA topoisomerases: essential enzymes and lethal targets. Annu Rev Pharmacol Toxicol 36:191-218
16. Chen G, Zelle WJ (1994) Increased poly(ADP-ribose) formation in cisplatin-resistant rat ovarian tumour cells. Anticancer Res 14:1462-1468
17. Colella G, Vikhanskaya F, Codegoni AM, Bonazzi C, D'Incalci M, Broggini M (1998) hMLH1 and hMSH2 expression and BAX frameshift mutations in ovarian cancer cell lines and tumors. Carcinogenesis 19:691-694
18. Corbett AH, Hong D, Osherhoff N (1993) Exploiting mechanistic differences between drug classes to define functional drug interaction domains on topoisomerase II. Evidence that several diverse DNA cleavage-enhancing agents share a common site of action on the enzyme. J Biol Chem 268:14 394-14 398
19. Crul M, Schellens JHM, Beijnen JH, Maliepaard M (1997) Cisplatin resistance and DNA repair. Cancer Treat Rev 23:341-366
20. 2-M cell cycle checkpoint arrest following ionizing radiation. Cancer Res 58:767-778
21. Dosch J, Christmann M, Kaina B (1998) Mismatch G-T binding activity and MSH2 expresssion is quantitatively related to sensity of cells to methylating agents. Carcinogenesis 19:567-573
22. Drummond JT, Li G-M, Longley MJ, Modrich P (1995) Isolation of an hMSH2-p160 heterodimer that restores DNA mismatch repair to tumour cells. Science 268:1909-1912
23. Drummond JT, Anthoney A, Brown R, Modrich P (1996) Cisplatin and adriamycin resistance are associated with MutLα and mismatch repair deficiency in an ovarian tumour cell line. J Biol Chem 271:19 645-19 648
24. 4-methylthymine, or the cisplatin-d(GpG) adduct. Proc Natl Acad Sci USA 93:6443-6447
25. Engelward BP, Dreslin A, Christensen J, Huszar D, Kurahara C, Samson L (1996) Repair-deficient 3-methyladenine DNA glycosylase homozygous mutant mouse cells have increased sensitivity to alkylation-induced chromosome damage and cell killing. EMBO J 15:945-952
26. Fink D, Nebel S, Aebi S, Zheng H, Cenni B, Nehmé A, Christen RD, Howell SB (1996) The role of DNA mismatch repair in platinum drug resistance. Cancer Res 56:4881-4886
27. Fink D, Zheng H, Nebel S, Norris PS, Aebi S, Lin TP, Nehmé A, Christen RD, Haas M, MacLeod CL, Howell SB (1997) In vitro and in vivo resistance to cisplatin in cells that have lost DNA mismatch repair. Cancer Res 57:1841-1845
28. Fink D, Aebi S, Howell SB (1998a) The role of DNA mismatch repair in drug resistance. Clin Cancer Res 4:1-6
29. Fink D, Nebel S, Norris PS, Baergen RN, Wilcynski SP, Costa MJ, Haas M, Cannistra SA, Howell SB (1998b) Enrichment for DNA mismatch repair-deficient cells during treatment with cisplatin. Int J Cancer 77:741-746
30. Fishel R, Lescoe MK, Rao MRS, Copeland NG, Jenkins NA, Garber J, Kane M, Kolodner R (1993) The human mutator gene homolog MSH2 and its association with hereditary non-polyposis colon cancer. Cell 75:1027-1038
31. Fishel R, Ewel A, Lee S, Lescoe MK, Griffith J (1994a) Binding of mismatched microsatellite DNA sequences by the human MSH2 protein. Science 266:1403-1405
32. Fishel R, Ewell A, Lescoe MK (1994b) Purified human MSH2 protein binds to DNA containing mismatched nucleotides. Cancer Res 54:5539-5542
33. Friedman HS, Johnson SP, Dong Q, Schold SC, Rasheed BKA, Bigner SH, Ali-Osman F, Dolan E, Colvin OM, Houghton P, Germain G, Drummond JT, Keir S, Marcelli S, Bigner DD, Modrich P (1997) Methylator resistance mediated by mismatch repair deficiency in a glioblastoma multiforme xenograft. Cancer Res 57:2933-2936
34. 6-methylguanine-DNA methyltransferase in mammalian cells by DNA-damaging treatments. Mol Cell Biol 11:4660-4668
35. Fujii H, Shimada T (1989) Isolation and characterization of cDNA clones derived from the divergently transcribed gene in the region upstream from the human dihydrofolate reductase gene. J Biol Chem 264:10 057-10 064
36. Genschel J, Littman SJ, Drummond JT, Modrich P (1998) Isolation of MutSbeta from human cells and comparison of the mismatch repair specificities of MutSbeta and MutSalpha. J Biol Chem 273:19 895-19 901
37. Gieseler F, Glasmacher A, Kampfe D, Wandt H, Nuessler V, Valsamas S, Kunze J, Wilms K (1996) Topoisomerase II activities in AML blasts and their correlation with cellular sensitivity to anthracyclines and epipodophyllotoxines. Leukemia 10:1177-1180
38. Gradia S, Acharya S, Fishel R (1997) The human recognition complex hMSH2-hMSH6 functions as a novel molecular switch. Cell 91:995-1005
39. Gu L, Hong Y, McCulloch S, Watanabe H, Li GM (1998) ATP-dependent interaction of human mismatch repair proteins and dual role of PCNA in mismatch repair. Nucleic Acids Res 26:1173-1178
40. Habraken Y, Sung P, Prakash L, Prakash S (1998) ATP-dependent assembly of a ternary complex consisting of a DNA mismatch and the yeast MSH2-MSH6 and MLH1-PMS1 protein complexes. J Biol Chem 273:9837-9841
41. 2 cell cycle checkpoint. Cancer Res 55:3721-3725
42. Her C, Doggett NA (1998) Cloning, structural characterization, and chromosomal localization of the human orthologue of Saccharomyces cerevisae MSH5 gene. Genomics 52:50-61
43. Hess P, Aquilinia G, Dogliotti E, Bignami M (1994) Spontaneous mutations at aprt locus in a mammalian cell line defective in mismatch recognition. Somatic Cell Mol Genet 20:409-421
44. Huang J, Papadopoulos N, McKinley AJ, Farrington SM, Curtis LJ, Wyllie AH, Zheng S, Willson JKV, Markowitz SD, Morin P, Kinzler KW, Vogelstein B, Dunlop MG (1996) APC mutations in colorectal tumours with mismatch repair deficiency. Proc Natl Acad Sci USA 93:9049-9054
45. Iaccarino I, Marra G, Palombo F, Jiricny J (1998) hMSH2 and hMSH6 play distinct roles in mismatch binding and contribute differently to the ATPase activity of hMutSα. EMBO J 17:2677-2686
46. Ibeanu G, Hartenstein B, Dunn WC, Chang LY, Hoffmann E, Coquerelle T, Mitra S, Kaina B (1992) Overexpression of human DNA repair protein N-methylpurine-DNA glycosylase results in the increased removal of N-methylpurines in DNA without a concomitant increase in resistance to alkylating agents in Chinese hamster ovary cells. Carcinogenesis 13:1989-1995
47. Kat A, Thilly WG, Fang W-H, Longley MJ, Li G-M, Modrich P (1993) An alkylation-tolerant, mutator human cell line is deficient in strand-specific mismatch repair. Proc Natl Acad Sci USA 90:6424-6428
48. King RW, Jackson PK, Kirschner MW (1994) Mitosis in transition. Cell 79:563-571
49. Kolodner R (1996) Biochemistry and genetics of eukaryotic mismatch repair. Genes Dev 10:1433-1442
50. 6-methylguanineDNA methyl-transferase and N-methylpurine-DNA glycosylase in melanoma cells with acquired drug resistance. Int J Cancer 80:744-750
51. Leach FS, Nicolaides NC, Papadopoulos N, Liu B, Jen J, Parsons R, Peltomäki P, Sistonen P, Aaltonen LA, Nyström-Lahti M, Guan X-Y, Zhang J, Meltzer PS, Yu J-W, Kao F-T, Chen DJ, Cerosaletti KM, Fournier REK, Todd S, Lewis T, Leach RJ, Naylor SL, Weissenbach J, Mecklin J-P, Järvinen H, Petersen GM, Hamilton SR, Greene J, Jass J, Watson P, Lynch HT, Trent JM, de la Chapelle A, Kinzier KW, Vogelstein B (1993) Mutations of a MutS homolog in hereditary nonpolyposis colorectal cancer. Cell 75:1215-1225
52. Li G-M, Modrich P (1995) Restoration of mismatch repair to nuclear extracts of H6 colorectal tumor cells by a heterodimer of human MutL homologs. Proc Natl Acad Sci USA 92:1950-1954
53. Lindblom A, Tannergard P, Werelius B, Nordenskjold M (1993) Genetic mapping of a second locus predisposing to hereditary non-polyposis colon cancer. Nat Genet 5:279-282
54. Liu L, Markowitz S, Gerson SL (1996) Mismatch repair mutations override alkyltransferase in conferring resistance to temozolomide but not to 1,3-bis(2-chloroethyl)nitrosourea. Cancer Res 56:5375-5379
55. Longley MJ, Pierce AJ, Modrich P (1997) DNA polymerase δ is required for human mismatch repair in vitro. J Biol Chem 272:10 917-10 921
56. Markowitz S, Wang J, Myeroff L, Parsons RE, Sun L, Lutterbaugh J, Fan RS, Zborowska E, Kinzier KW, Vogelstein B, Brattain M, Willson JKV (1995) Inactivation of the type II TGF-β receptor in colon cancer cells with microsatellite instability. Science 268:1336-1338
57. Mello JA, Acharya S, Fishel R, Essigmann JM (1996) The mismatch-repair protein hMSH2 binds selectively to DNA adducts of the anticancer drug cisplatin. Chem Biol 3:579-589
58. Modrich P (1991) Mechanisms and biological effects of mismatch repair. Annu Rev Genet 25:229-253
59. Modrich P, Lahue R (1996) Mismatch repair in replication fidelity, genetic recombination and cancer biology. Annu Rev Biochem 65:101-133
60. Moggs JG, Szymkowski DE, Yamada M, Karran P, Wood RD (1997) Differential human nucleotide excision repair of paired and mispaired cisplatin-DNA adducts. Nucleic Acids Res 25:480-490
61. 2-terminal kinase and c-Abl kinase in DNA mismatch repair-proficient and -deficient cells exposed to cisplatin. Cancer Res 57:3253-3257
62. Nicolaides NC, Papadopoulos N, Liu B, Wie Y-F, Carter KC, Ruben SM, Rosen CA, Haseltine WA, Fleischmann RD, Fraser CM, Adams MD, Venter JC, Dunlop MG, Hamilton SR, Petersen GM, de la Chapelle A, Vogelstein B, Kinzier KW (1994) Mutations of of two PMS homologues in hereditary nonpolyposis colon cancer. Nature 371:75-80
63. Palombo F, Gallinari P, Iaccarino I, Lettieri T, Hughes M, D'Arrigo A, Truong O, Hsuan JJ, Jiricny J (1995) GTBP, a 160-kilodalton protein essential for mismatch binding activity in human cells. Science 268:1912-1914
64. Papadopoulos N, Nicolaides NC, Wei YF, Ruben SM, Carter KC, Rosen CA, Haseltine WA, Fleischmann RD, Fraser CM, Adams MD, Venter JC, Hamilton SR, Petersen GM, Watson P, Lynch HT, Peltomäki P, Mecklin J-P, de la Chapelle A, Kinzier KW, Vogelstein B (1994) Mutation of a mutL homolog in hereditary colon cancer. Science 263:1625-1629
65. Papadopoulos N, Nicolaides NC, Liu B, Parsons R, Lengauer C, Palombo F, D' Arrigo A, Markowitz S, Willson JK, Kinzier KW, Jirciny J, Vogelstein B (1995) Mutations of GTBP in genetically unstable cells. Science 268:1915-1917
66. Paquis-Fluckinger V, Sanctucci-Darmanin S, Paul R, Saunieres A, Turc-Carel C, Desnuelle C (1997) Cloning and expression analysis of a meiosis-specific MutS homolog: the human MSH4 gene. Genomics 44:188-194
67. Peltomäki P, Aaltonen LA, Sistonen P, Pylkkänen L, Mecklin JP, Järvinen H, Green JS, Jass JR, Weber JL, Leach FS, Petersen GM, Hamilton SR, de la Chapelle A, Vogelstein B (1993) Genetic mapping of a locus predisposing to human colorectal cancer. Science 260:810-812
68. 6-Methylguanine-DNA methyltransferase (MGMT) on the cytotoxic and recombinogeenic activity of difference antineoplastic drugs. Int J Cancer 65:506-512
69. Prolla TA, Pang Q, Alani E, Kolodner RD, Liskay RM (1994) MLH1, PMS1, and MSH2 interactions during the initiation of DNA mismatch repair in yeast. Science 265:1091-1093
70. Rampino N, Yamamoto H, Ionov Y, Li Y, Sawai H, Reed JC, Perucho M (1997) Somatic frame shift mutations in the BAX gene in colon cancers of the microsatellite mutator phenotype. Science 275:967-969
71. Reenan RAG, Kolodner RD (1992) Isolation and characterization of two Saccharomyces cerevisae genes encoding homologs of the bacterial HexA and MutS mismatch repair proteins. Genetics 132:963-973
72. Rhyu MS (1996) Molecular mechanisms underlying herediatary nonpolyposis colorectal carcinoma. J Natl Cancer Inst 88:240-251
73. Risinger JI, Barret JC, Watson P, Lynch HT, Boyd J (1996) Molecular genetic evidence of the occurrence of breast cancer as an integral tumor in patients with the hereditary nonpolyposis colorectal carcinoma syndrome. Cancer 77:1836-1846
74. Sancar A, Hearst JE (1993) Molecular matchmakers. Science 259:1415-1420
75. Shin KH, Yang YM, Park JG (1998) Absence or decreased levels of the hMLH1 protein in human gastric carcinoma cell lines: implications of hMLH1 in alkylation tolerance. J Cancer Res Clin Oncol 124:421-426
76. Suzuki H, Komiya, A, Aida S, Akimoto S, Shiraishi T, Yatani R, Igarashi T, Shimazaki J (1995) Microsatellite instability and other molecular abnormalities in human prostate cancer. Jpn J Cancer Res 86:956-961
77. Swann PF, Waters TR, Moulton DC, Xu YZ, Zheng Q, Edwards M, Mace R (1996) Role of postreplicative DNA mismatch repair in the cytotoxic action of thioguanine. Science 273:1109-1111
78. Thibodeau SN, Bren G, Schaid D (1993) Microsatellite instability in cancer of the proximal colon. Science 260:816-819
79. Umar A, Buermeyer AB, Simon JA, Thomas DC, Clark AB, Liskay RM, Kunkel TA (1996) Requirement for PCNA in DNA mismatch repair at a step preceding DNA resynthesis. Cell 87:65-73
80. Urade M, Sugi M, Mima T, Ogura T, Matsuya T (1989) High induction of human poly(ADP-ribose) polymerase activity in bleomycin-resistant HeLa cells. Jpn J Cancer Res 80:464-468
81. Vaisman A, Varchenko M, Umar A, Kunkel TA, Risinger JI, Barret JC, Hamilton TC, Chaney SG (1998) The role of hMLH1, hMSH3, and hMSH6 defects in cisplatin and oxaliplatin resistance: correlation with replicative bypass of platinum-DNA adducts. Cancer Res 58:3579-3585
82. Walker PR, Smith C, Youndale T, Leblanc J, Whitfield JF, Sikorska M (1991) Topoisomerase II-reactive chemotherapeutic drugs induce apoptosis in thymocytes. Cancer Res 51:1078-1085
83. 6-methylthioguanine. Biochemistry 36:2501-2506
84. Welch PJ, Wang JYJ (1993) A C-terminal protein-binding domain in the retinoblastoma protein regulates nuclear c-Abl tyrosine kinase in the cell cycle. Cell 75:779-790
85. Wildenberg J, Meselson M (1975) Mismatch repair in heteroduplex DNA. Proc Natl Acad Sci USA 72:2202-2206